Heart failure market to grow at 9.6 per cent CAGR in 7MM during 2022-32 GlobalData Jan 8, 2025 GlobalData’s report reveals that the US will contribute the most to the growth of the HF market due to the higher prevalence of HF…
Eli Lilly’s Zepbound holds possibility to dominate obesity market GlobalData Dec 31, 2024 Recently, Eli Lilly announced the results from its SURMOUNT-5 trial, comparing Zepbound and Wegovy’s efficacy on equal grounds
